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Protein p6 of the Bacillus subtilis phage 429 binds
with low sequence specificity to DNA through the
minor groove, forming a multimeric nucleoprotein
complex that activates the initiation of 429 DNA
replication. Deletion analysis suggested that the N-
terminal part of protein p6, predicted to form an
amphipathic a-helix, is involved in DNA binding. We
have constructed site-directed mutants at the polar
side of the putative a-helix. DNA binding and activation
of initiation of 429 DNA replication were impaired in
most of the mutant proteins obtained. A 19 amino
acid peptide comprising the N-terminus of protein p6
interacted with a DNA fragment containing high-
affinity signals for protein p6 binding with -50-fold
higher affinity than the peptide corresponding to an
inactive mutant. Both wild-type peptide and protein
p6 recognized the same sequences in this DNA frag-
ment. This result, together with distamycin competition
experiments, suggested that the wild-type peptide also
binds to DNA through the minor groove. In addition,
CD spectra of the wild-type peptide showed an increase
in the a-helical content when bound to DNA. All these
results indicate that an a-helical structure located in
the N-terminal region of protein p6 is involved in DNA
binding through the minor groove.
Key words: a-helix/DNA minor groove binding/DNA
replication/low sequence specificity protein/phage 429
Introduction
Structural studies of DNA binding proteins have allowed
the characterization of many protein motifs involved in
DNA recognition. Most of them recognize DNA-specific
sequences through the major groove mainly by hydrogen
bonding with bases and electrostatic interactions with
phosphate groups. On the other hand, some DNA binding
motifs recognize a DNA structure rather than a specific
sequence (reviewed in Churchill and Travers, 1991); a
common property of these motifs is their interaction with
the DNA through the minor groove. The amount of
information available forDNA binding motifs in sequence-
specific DNA binding proteins (reviewed in Pabo and
Sauer, 1992) is much smaller for proteins of low sequence
specificity, despite the fact that some structural motifs
have been described. Thus, an exposed loop has been
demonstrated by X-ray diffraction of DNase I complexed
with DNA (Suck et al., 1988), an antiparallel 5-sheet has
been proposed to interact with DNA for HU (White et al.,
1989), and a P-tum has been suggested for histones HI
and H2B (Suzuki, 1989), HMG-1 (Reeves and Nissen,
1990) and DATI protein (Reardon et al., 1993). The TATA
binding protein also interacts with the DNA minor groove,
although recognizing a specific sequence; the structure of
the protein-DNA complex has revealed that the binding
domain consists of 5-sheets and 5-loop protrusions
(J.L.Kim et al., 1993; Y.Kim et al., 1993).
Protein p6 from Bacillus subtilis phage 429 is required
in vivo for viral DNA replication (Carrascosa et al., 1976;
Mellado et al., 1980), and activates in vitro the initiation
of 429 DNA replication (Blanco et al., 1986), as well as
the transition to elongation (Blanco et al., 1988). Phage
429 replicates its linear, double-stranded (ds) DNA
genome by a protein-priming mechanism in which the
initiation complex, formed by the covalent linkage of the
5' terminal nucleotide (dAMP) to the terminal protein
(TP), catalyzed by the phage DNA polymerase is further
elongated by the same DNA polymerase by a strand-
displacement mechanism (reviewed in Salas, 1991).
Protein p6 activates the initiation of 429 DNA replication
by forming a multimeric nucleoprotein complex at the
replication origins (Prieto et al., 1988; Serrano et al.,
1989) located at the genome ends. The path of the DNA
in the complex has been characterized as a right-handed
DNA superhelix wrapped around a protein p6 multimeric
core, and the parameters that define the superhelix have
been determined (Serrano et al., 1993). Protein p6 has
103 amino acids (Murray and Rabinowitz, 1982), forms
dimers in solution (Pastrana et al., 1985) and binds to
DNA through the minor groove (Serrano et al., 1990). It
is one of the most abundant proteins in 429-infected
B.subtilis cells, with -3X 106 copies per cell in the late
stages of infection (Serrano et al., 1994), and it has been
shown to interact in vitro with the whole viral genome
suggesting that it may have a more general role in genome
packaging and organization (Gutierrez et al., 1994). The
fact that the protein p6-DNA complex can be formed on
DNA regions of >1 kb (Gutierrez et al., 1994) indicates
that protein p6 must be able to interact with a large variety
of sequences, although it recognizes preferentially those
showing a tendency to bend with a defined periodicity
(Serrano et al., 1993). Protein p6 thus corresponds to the
class of low sequence specificity ds DNA binding proteins
that, like proteins such as HU and the HMG-1 family, can
act as architectural elements in various DNA transactions
(Grosschedl et al., 1994).
Previous studies with protein p6 N-terminal deletion
mutants suggested that the N-terminus of protein p6 is
involved in DNA binding (Otero et al., 1990). Since this
region has been shown to have a strong tendency to form
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an amphipathic a-helix, the positive face of the helix
was an attractive candidate for binding to the phosphate
backbone of the DNA. In this paper we have tested this
hypothesis by two experimental approaches: (i) using
protein p6 mutants directed to the N-terminus, and (ii)
with synthetic peptides corresponding to this region. The
results obtained allow us to propose that the protein p6
N-terminal region adopts an a-helical conformation that
is involved in DNA interaction, and constitutes a novel
protein motif for minor groove DNA binding.
Results
Site-directed mutagenesis at the protein p6
N-terminal region
Protein p6 mutants in which five and 13 N-terminal amino
acids were deleted showed impaired and undetectable
DNA binding activities, respectively (Otero et al., 1990),
suggesting that this region was involved in DNA binding.
The N-terminus of protein p6 is rich in basic amino acids,
and secondary structure predictions (Chou and Fasman,
1978; Gamier et al., 1978) showed a high tendency to
form an a-helix. This putative a-helix is predicted to have
a strong amphipathic character with a hydrophobic moment
of 0.48 for the first 18 residues (Saier and McCaldon,
1988). To investigate further the involvement of this region
in DNA binding, we designed site-directed mutants in
which positively charged or polar residues of the hydro-
philic side of the predicted helix were substituted by
either alanine, to preserve protein secondary structure
(Cunningham and Wells, 1989), or lysine, to increase the
positive charge. Figure 1 shows the 19 N-terminal amino
acid sequence arranged as an a-helix, as well as the amino
acid substitutions introduced. An M13-derivative phage
containing wild-type gene 6 was constructed and site-
directed mutagenesis was performed. The mutated genes
were cloned into an expression vector under the control
of the bacteriophage x PL promoter. Protein p6 mutants
were overproduced and purified up to at least 90%
homogeneity. The standard procedure used for wild-type
protein p6 purification (Pastrana et al., 1985) had to be
modified since most of the mutant proteins failed to bind
to a phosphocellulose column. This different behavior was
in agreement with amino acid changes affecting the DNA
binding domain.
DNA binding affinity of protein p6 mutants
DNA gel retardation studies provided the first indication
that some of these mutant proteins had altered DNA
binding affinities. Thus, a higher amount of protein p6K2A
mutant was required to obtain the same DNA retardation
as that with the wild-type protein, and no retardation was
achieved with the p6R6A mutant protein (results not
shown). The formation of the multimeric protein p6-DNA
complex gives rise, by DNase I footprinting, to a character-
istic pattern of hypersensitive bands regularly spaced every
24 bp flanked by protected regions (Prieto et al., 1988).
Hence, DNase I footprinting was the method of choice
for DNA binding studies, since it not only allows the
estimation of binding affinities but also the assessment of
the structure of the nucleoprotein complex formed. Figure
2 shows the results obtained with representative mutants.
The complexes formed by all the mutant proteins, except
A,K
A,K A,K
Fig. 1. Protein p6 N-terminus. a-Helical projection of the N-terminal
19 amino acids. The projection down the helix axis displays the
location of the side-chain a-carbons along the peptide backbone. The
amino acid substitutions performed are indicated by arrows.
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Table I. Summary of DNA binding affinities and initiation of 429
DNA replication activities of protein p6 mutants
Protein p6 DNA Initiation activity protein Maximal
bindinga dose for half-maximal stimulationc
stimulationb
wt 1.0 1.0 100
N14A 1.1 0.9 98
N14K 1.6 1.9 72
T9K 3.2 2.1 105
T9A 3.5 4.8 107
KIOA 4.2 5.0 39
Q5A 4.5 3.6 98
K2A 5.2 8.2 79
Q5K 6.6 4.7 76
K17A 7.4 13.8 98
R6A > 14 >32 <4
aProtein amount necessary for 50% complex formation normalized to
that of the wild-type protein (0.85 jg).
bProtein amount necessary for half-maximal stimulation in the
initiation reaction normalized to wild-type protein (0.25 ,ug).
cMaximal stimulation value obtained in the initiation reaction, relative
to that of the wild-type protein.
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Fig. 4. (A) Dimer formation by p6 wild-type and p6R6A mutant
proteins. Proteins, 3 ig each, were crosslinked with glutaraldehyde
and run in SDS-PAGE along with untreated samples and molecular
weight markers. (B) Interference assay of p6 wild-type and p6R6A
mutant proteins. The indicated amounts of p6 wild-type and p6R6A
mutant proteins were used, either separately or together, in DNase I
footprinting with the 429 DNA HindIlI right terminal fragment.
(C) The same as in (B), except that they were assayed in vitro for
initiation of 429 DNA replication. The mobility of the initiation
complex (TP-dAMP) is shown by an arrow.
K10A than that required for the wild-type protein to reach
maximal activation. The other mutant proteins, with the
exception of p6KIOA, reached a maximal activation of at
R6A least 70% of that of the wild-type protein, although at a
higher protein concentration. Table I summarizes the
1 2 3 4 5 6 7 8 behavior of all the mutant proteins, and shows the maximal
protein,
'g stimulation achieved and the protein concentrations needed
ation of initiation of 029 DNA replication by protein p6. to obtain half-maximal stimulation. The mean values from
e and indicated protein p6 mutants were assayed, at at least three different experiments were normalized for
Lein concentrations, for activation of 429 DNA initiation those obtained for the wild-type protein. Mutant proteins
, shown as the percentage of the maximal stimulation were also tested in their capacity to stimulate the elongation
ithe wild-type protein p6. of the initiation complex (TP-dAMP) (Blanco et al.,
1988) in a truncated elongation assay (Blasco et al., 1993),
binding affinity was calculated as the protein where they showed the same behavior as in the initiation
ion required to obtain 50% of full protection. assay (results not shown).
Table I shows the mean values from two different experi-
ments with all the mutant proteins, normalized for those
obtained for the wild-type protein. The effective binding
constant of wild-type protein p6 to 429 DNA has been
estimated to be -105 M-1 (Gutierrez et al., 1994).
Activity of protein p6 mutants in the initiation of
replication
The functionality of the protein p6 mutants was also tested
by their ability to stimulate the initiation of 029 DNA
replication in an in vitro assay with purified proteins
(Pastrana et al., 1985). Figure 3 shows the results obtained
with the mutant proteins shown above (see Figure 2).
While p6N14A mutant protein exhibited essentially the
same activity as the wild-type protein, the rest of the
mutant proteins showed to different extents a decrease in
the activation of the initiation reaction. As expected from
the DNA binding results, p6R6A mutant protein did not
Dimer formation of protein p6 mutants
It has been reported that protein p6 forms dimers in
solution (Pastrana et al., 1985), and most probably binds
to DNA as a dimer (Serrano et al., 1990). The impaired
DNA binding of the protein p6 mutants described above
could be explained if mutations were affecting either the
general folding of the protein or the dimerization domain,
rather than the DNA binding domain itself. To rule out
the possibility that dimerization was affected in the mutant
proteins, we set up an assay in which protein p6 monomers
were crosslinked with glutaraldehyde, and protein p6
dimers were detected by SDS-PAGE. Figure 4A shows
that the p6R6A mutant protein forms dimers to the same
extent as the wild-type protein. A similar behavior was
observed for all the other mutant proteins (not shown).
These results indicate that the mutations do not affect the
dimerization domain and suggest that there are no major
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Fig. 5. DNase I footprinting of protein p6 N-terminal peptides. (A) DNase I footprint of protein p6 and wild-type peptide with a DNA fragment
(concatemer) containing 10 tandem repeats of a 24 bp sequence with high affinity for protein p6 binding (Serrano et al., 1993) or the 029 HindIlI
right terminal fragment (right origin). The amounts used with the concatemer and the right origin were for the peptide, 1 and 0.5 jig, and for protein
p6, 6 and 2 ,ug, respectively. (B) DNase I footprint of the indicated amounts of either wild-type or R6A peptides with the concatemer fragment.
alterations in the general folding of the protein. Further-
more, crosslinking studies suggested the formation of
mixed dimers of wild-type and R6A mutant p6 proteins
(not shown). Figure 4B shows DNase I footprints of wild-
type together with p6R6A mutant proteins, demonstrating
that p6R6A strongly interfered with wild-type protein p6
in DNA binding. This can be explained by the formation
of inactive heterodimers, in agreement with the indication
that the R6A mutation does not affect dimerization. Figure
4C shows that the same effect is observed in the in vitro
assay for initiation of 429 DNA replication: the p6R6A
mutant protein, that did not activate the formation of
the initiation complex (TP-dAMP; see also Figure 3),
strongly impaired the activation of TP-dAMP formation
by the wild-type protein p6 when they were added together.
DNA binding of N-terminal peptides
The DNA binding capacity of the N-terminal region
of protein p6 was investigated further using synthetic
oligopeptides of 19 amino acids with the N-terminal
sequence of the wild-type protein p6 (wild-type peptide)
and that of the p6R6A mutant protein (R6A peptide).
Figure 5A shows the DNase I footprint of protein p6 and
the wild-type peptide with a DNA fragment containing a
protein p6 high-affinity binding sequence, 24 bp long,
repeated in tandem (Serrano et al., 1993), hereafter the
concatemer fragment. The hypersensitive sites induced by
protein p6 were also induced by the peptide (indicated by
asterisks), suggesting that the peptide recognizes the same
sites in the DNA fragment; however, the formation of the
protein p6-DNA complex gives rise to protections to
DNase I digestion not observed with the wild-type peptide,
indicating that the peptide cannot form such a multimeric
complex. The periodicity of the digestion pattern obtained
with the wild-type peptide reflects, therefore, the sequence
repetition in the DNA fragment. Figure 5A also shows
the DNase I footprint of the wild-type peptide, and of
protein p6 as control, to the )29 DNA right terminal
fragment. The wild-type peptide changed the footprint
pattern, mainly inducing hypersensitivities and occasion-
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Fig. 6. DNase I footprinting of wild-type peptide and distamycin.
DNase I footprinting was performed with the 029 DNA Hindlll right
terminal fragment, 5 jig (120 jiM) of wild-type peptide and the
indicated concentrations of distamycin. Filled and empty arrows
indicate hypersensitivities induced by the wild-type peptide that
remained up to and 10-2 jiM distamycin, respectively.
ally a few protections (see also Figure 6). In contrast to
the pattern observed with protein p6, the hypersensitivities
were not periodic, further indicating that the wild-type
peptide does not form a multimeric complex.
Figure 5B shows the binding to the concatemer fragment
of different concentrations of wild-type and R6A peptides.
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Fig. 7. CD spectra of the wild-type peptide in the absence and
presence of DNA. Molar ellipticity (0) is expressed in 'cm2dmol- at
different wavelengths. Spectrum of the wild-type peptide alone (0), or
in the presence of DNA after subtraction of the spectrum of the DNA
alone (*).
Although the same DNase I footprint pattern was observed
in both cases, the R6A peptide required a concentration
-50-fold higher than that for the wild-type peptide. This
result is in agreement with that shown in Figure 2, in
which the p6R6A mutant protein was not able to bind
DNA with a protein concentration 10-fold higher than
that required for the wild-type protein. Furthermore, the
R6A peptide bound the 429 DNA right terminal fragment
with a 100-fold lower affinity than the wild-type peptide
(result not shown).
All these results are in agreement with those obtained
with the site-directed protein mutants, supporting the
implication of the N-terminal region, and in particular the
arginine residue at position 6, in DNA binding.
Competition of wild-type peptide and distamycin
for DNA binding
Protein p6 binds to DNA through the minor groove
(Serrano et al., 1990). Although the result shown in
Figure 5A suggested that the peptide interacted with the
concatemer fragment in a way similar to protein p6, to
assess whether the wild-type peptide binds to DNA also
through the minor groove we challenged the peptide with
distamycin, a minor groove DNA binding drug (Coll et al.,
1987). Figure 6 shows the DNase I footprint of distamycin
to the 429 DNA right terminal fragment, in the absence
or presence of the wild-type peptide. Distamycin largely
protected the fragment from DNase I digestion, and the
protection was total at a concentration of 10 tM. Figure
6 also shows, as a control, the DNase I footprint of the
wild-type peptide alone (see also Figure SA), where
induced hypersensitive sites can be clearly observed.
However, when the peptide and distamycin were added
together, the peptide-induced hypersensitivities gradually
decreased as distamycin concentration increased, prob-
ably reflecting differences of the peptide affinity for
different DNA sites. This result is consistent with a
displacement of the DNA-bound peptide by distamycin.
As a control, the same experiments were performed
with the major groove-binder methyl green (Zimmer and
Wahnert, 1986), and no effect on peptide binding was
obtained with drug concentrations up to 1 ,uM (results not
shown), despite the fact that distamycin and methyl
green have similar DNA binding affinities (Kumar and
Muniyappa, 1992). Altogether, these results suggest that
the peptide binds to the DNA also through the minor
groove.
CD studies of DNA-induced conformational
changes of the peptide
Once it was determined that the N-terminal peptide of
protein p6 was involved in DNA binding, it was important
to study the secondary structure of the peptide in solution
and the effect of DNA binding. This was approached by
CD, as has been performed for other cases (Zlotnick and
Brenner, 1988; Anthony-Cahill et al., 1992; Fisher et al.,
1993). The spectrum of the DNA at wavelengths >240 nm
was essentially not affected by the presence of the peptide
(results not shown), indicating that the structure of the
DNA remained unchanged. Therefore, structural changes
in the peptide due to the presence of DNA can be directly
analyzed by subtracting the spectrum of the DNA alone
from that of the DNA together with the peptide. Figure 7
shows the CD spectrum of the peptide alone, in which
the -200 nm minimal peak reflects a mostly random
conformation, and the shoulder at -220 nm suggests a
small amount of a-helix. Essentially the same spectrum
was obtained with the R6A peptide (not shown); thus,
this mutation did not seem to alter the conformation of
the wild-type peptide. Figure 7 also shows the CD spectrum
of the peptide in the presence of DNA from which the
spectrum of the DNA alone was subtracted. It can be
observed that the ellipticity at -220 nm was shifted with
respect to that of the peptide alone, indicating that the
peptide undergoes a transition to an a-helical structure
upon DNA binding.
Discussion
While many protein motifs have been described for
sequence-specific recognition through the DNA major
groove (Pabo and Sauer, 1992), the available information
for non-sequence-specific DNA recognition through the
minor groove is scant. Phage 429 protein p6 binds to
DNA through the minor groove (Serrano et al., 1990) and
it does not recognize a specific nucleotide sequence
(Serrano et al., 1989). However, it shows a preferential
binding to sequences with defined bendable properties
that favor the formation of the multimeric complexes with
DNA (Serrano et al., 1993). Therefore, it was interesting
to study the structural basis of the binding of protein p6
to DNA.
Protein p6 deletion analysis (Otero et al., 1990)
suggested that the N-terminal region was involved in
DNA binding. Moreover, secondary structure predictions
indicated a strong tendency of this region to adopt an
amphipathic a-helical conformation. In this work we have
studied, by site-directed mutagenesis, the involvement in
DNA binding of amino acid residues of the polar side of
the putative a-helix, with the aim of characterizing a
protein motif for DNA binding. The DNA binding in most
of the mutants studied was impaired to different extents.
However, only the p6R6A mutant protein was completely
inactive. Therefore, arginine at position 6 seems to estab-
lish critical contacts with DNA. The rest of the residues
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are not so critical, and the asparagine at position 14 does
not seem to be relevant. Mutants in which a positive
charge was introduced did not, in general, lead to a higher
binding affinity; in fact, a lysine residue at positions 5 or
14 showed lower activities than alanine, though at position
9 the opposite effect was observed. As expected, the DNA
affinity was more dependent on the position of the residue
changed than on the increase of the positive charge. The
possibility that these mutations affected the general folding
of the protein or the dimerization domain was ruled out
since they showed a similar ability as the wild-type protein
to form dimers.
In agreement with previous results (Serrano et al., 1989;
Otero et al., 1990), a good correlation between DNA
binding affinity and activation of 429 DNA initiation of
replication was observed. When assayed for initiation of
429 DNA replication, all the mutant proteins required
higher amounts than the wild-type protein to reach max-
imal stimulation, with the exceptions of p6N14A mutant
protein, which behaved as the wild-type, and p6R6A
mutant protein, which was inactive. The maximal stimula-
tion values obtained with the mutant proteins were at least
70% of that reached by wild-type protein p6. However,
the p6K1OA mutant protein leveled off at 40%, despite
the fact that it exhibited the same DNase I footprint pattern
as the wild-type protein and therefore the structure of the
nucleoprotein complex was the same. This result suggests
that this residue, besides its role in DNA binding, could
have an additional role in the initiation ofDNA replication.
Activation of 429 DNA replication requires the specific
positioning of protein p6 with respect to the 429 replication
origin (Serrano et al., 1989), suggesting that the proteins
involved in initiation (DNA polymerase and/or TP) could
interact directly with protein p6. Though interaction of
protein p6 with initiation proteins has not been demon-
strated directly, it is conceivable that this interaction could
be affected in the p6K1OA mutant protein.
An in vivo functional assay for protein p6 has been
developed, in which protein p6-producing B.subtilis cells
support DNA replication of a 429 sus 6 mutant phage.
This assay has been used to analyze the effect of K2A
and R6A mutations in 429 DNA replication in vivo. In
cells producing p6K2A mutant protein, the rate of 429
DNA synthesis was reduced markedly with respect to
those producing wild-type protein. The R6A mutation was
much more detrimental, and no significant viral DNA
synthesis was detected (Bravo et al., 1994). These results
are in agreement with those obtained in vitro, supporting
the conclusion that lysine at position 2 is involved in
DNA binding and arginine at position 6 is essential for
that activity.
The study of the involvement of the N-terminal region
of protein p6 in DNA binding was also approached using
a synthetic peptide comprising the 19 N-terminal amino
acids of protein p6 and studying its ability to interact with
a DNA fragment containing high-affinity binding sites for
protein p6 (Serrano et al., 1993). The peptide was able
not only to bind to the fragment, but also to recognize the
same signals as protein p6. The hypersensitivities induced
by the peptide reflect local distortions in the DNA, making
it more accessible to DNase I, i.e. widening the DNA
minor groove. The same effect has been reported for DNA
minor groove binding drugs like distamycin or actinomycin
(Fox and Waring, 1984). The competition observed for
DNA binding between the peptide and distamycin, together
with the fact that the peptide binds to high-affinity
sequences in a way similar to that of protein p6, suggest
that the peptide binds to the DNA also through the minor
groove. The importance of the arginine residue at position
6 in DNA binding is reinforced by the fact that the peptide
containing the mutation R6A bound to DNA with 50- to
100-fold less affinity than the wild-type peptide. The
secondary structure of the peptide, as shown by CD
studies, was mostly random conformation. However, the
spectra of the peptide in the presence of DNA showed a
decrease of ellipticity at -220 nm, suggesting an increase
in a-helical content upon DNA binding. It is possible that
this region is more structured in the protein than in
the peptide, and it may have an a-helical conformation
stabilized by either DNA interactions, as in RecA (Kumar
et al., 1993), or other regions of the protein. It is interesting
to note that an extensive computer search has revealed
that nearly 10% of all viral proteins contain potential N-
terminal a-helices with strong amphipathic character, 55%
of which interact functionally with nucleic acids (Saier
and McCaldon, 1988).
The DNA binding motifs that have been proposed
previously for proteins that bind through the minor groove
with low sequence specificity differ from the one proposed
here. An exposed loop has been described for DNase I
(Suck et al., 1988), the only case in which structural data
of the protein-DNA interaction are available. Other motifs
have been suggested, such as an antiparallel ,3-sheet in
E.coli histone-like protein HU (White et al., 1989) and a
,-turn structure (Suzuki et al., 1993) in the SPKK motif
found in the N-terminal tails of histones HI and H2B
(Suzuki, 1989), in HMG-1 proteins (Reeves and Nissen,
1990) and in yeast DATI protein (Reardon et al., 1993).
In a few instances, a-helical structures have also been
suggested. Protamines, with a high content of basic
residues, have been proposed to interact with the phosphate
groups through both the major and minor grooves (Warrant
and Kim, 1978). In RecA, CD studies have shown an
increase in a-helical content upon DNA interaction
(Kumar et al., 1993), suggesting that the DNA binding
domain, probably located in two disordered regions shown
in the 3-D structure (Story et al., 1992), has a potential
a-helical structure. In the case of the HMG domain of
SRY, the partial intercalation of a non-polar side chain in
the minor groove led to the prediction of an insertion of
an a-helix into a widened minor groove (King and Weiss,
1993). The results presented in this paper, in contrast,
indicate a different type of interaction for protein p6. The
amino acids shown to be involved in DNA binding are
basic or polar, and whereas protein p6 dimer formation
increases with the ionic strength (R.Freire, unpublished
results), DNA binding decreases (Prieto et al., 1988).
Therefore we conclude that protein p6 interaction with
DNA is mainly electrostatic. In addition, the proposed a-
helix must be positioned outside of the minor groove,
since the dimensions of the groove would not allow the
accommodation of an a-helix (Kim, 1983), especially in
this case in which the DNA is wrapped around a protein
core, so protein p6 faces a narrowed minor groove (Serrano
et al., 1990).
For a decapeptide motif found in histones HI and H4,
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it has been proposed that on theoretical grounds an a-
helix could interact with both DNA strands bordering a
relatively narrow minor groove. The amino acids, mostly
basics at positions 3, 4, 7 and 8 of the helix, can
be arranged in a spatial orientation that is precisely
complementary to that of the phosphate oxygen atoms of
DNA (Tumell et al., 1988). The amino acid residues of
protein p6 found to be involved in DNA binding (Glu5,
Arg6, Thr9 and Lys 10) can be arranged in the same
manner. Thus, the N-terminal region of protein p6 could
interact with the DNA backbone in a similar way, constitut-
ing the first experimental evidence of the proposed model
(Tumell et al., 1988). Two additional amino acids flanking
the central part of the motif, Lys2 and Lys17, are also
involved in this interaction. This would increase in three
turns the length of the helix. The additional contacts could
explain the strong distortion imposed by protein p6 in the
DNA path (Serrano et al., 1993) and could be related to
the DNase I hypersensitivities induced by the protein p6
N-terminal peptide.
In conclusion, we propose that the N-terminal region
of protein p6 constitutes a new protein domain for DNA
binding in which the polar side of an amphipathic a-helix
interacts with the DNA backbone through a narrowed
minor groove.
Materials and methods
Chemicals, oligopeptides, oligonucleotides, nucleotides and
enzymes
Glutaraldehyde was obtained from Serva. Synthetic oligonucleotides
were obtained from Isogen. The peptides NH2-AKMMQREITKTTVNV-
AKMV-amide (wild-type peptide) and NH2-AKMMQAEITKTTVNVA-
KMV-amide (R6A peptide) were obtained from Multiple Peptide System
and their purity was >90% as determined by HPLC. The site-directed
mutagenesis kit and [ox-32P]dATP (400 and 3000 Ci/mmol) were pur-
chased from Amersham International plc. DNase I was obtained from
Worthington; restriction endonucleases, Klenow fragment of DNA poly-
merase I and T4 DNA ligase were acquired from New England Biolabs.
Site-directed mutagenesis and expression of protein p6
mutants
The DNA fragment containing the 429 gene 6 was obtained from
plasmid pRP8 (Pastrana et al., 1985) by digestion with AccI and EcoRI.
The cohesive ends of the gene 6-containing fragment were filled in with
the Klenow fragment of DNA polymerase I and then cloned into the
SmaI site of the Ml3mpl9 replicative form. This construction, named
mp6wt, was used as template for site-directed mutagenesis, carried out
essentially as described (Sayers et al., 1988). The EcoRI-HindIII
fragment of mp6wt derivatives containing the mutant genes was isolated
and cloned into the expression vector pPLc28 (Remaut et al., 1981),
under the control of the PL promoter of phage X. All the mutant genes
were entirely sequenced (Sanger et al., 1977) to confirm that no other
mutation was present. Overproduction of the different mutant proteins
was carried out essentially as described in Ecoli NFI cells containing
the thermosensitive cI 857 repressor (Pastrana et al., 1985).
Purification of protein p6 mutants
E.coli cells overproducing protein p6 mutants were disrupted by grinding
with alumina, and suspended in buffer A (50 mM Tris-HCI, pH 7.5,
5% glycerol) containing 1 M NaCl; alumina and cell debris were
removed by centrifugation. Polyethyleneimine (PEI) was added up to
0.25% to the supematant, after adjusting absorbance at 260 nm to 120 U/
ml, and centrifuged for 10 min at 10 000 g to remove DNA. The
supernatant was made to 0.35 M NaCl with buffer A, and the protein
p6 mutants were recovered in the pellet after centrifugation as above.
To eliminate PEI, the pellet was resuspended in 0.4 M NaCl, and the
protein was precipitated with ammonium sulfate to 70% saturation. The
pellet was dissolved in buffer A and applied to a heparin-agarose
column. Protein p6 mutants were eluted with buffer A containing 0.20
or 0.25 M NaCI, depending on the mutant. The samples were further
subjected to chromatography through phenyl-Sepharose columns equilib-
rated in buffer A containing 0.25 M NaCI; protein p6 mutants were
collected in the flow-through. After this step most of the mutant proteins
were at least 90% homogeneous. In some cases, a 15-30% glycerol
gradient was performed to reach that purity. Protein concentration was
determined by the Lowry method (Lowry et al., 1951).
Initiation of 429 DNA replication assay
The reaction mixture contained, in 25 1l, 50 mM Tris-HCI, pH 7.5,
10 mM MgCl2, 20 mM ammonium sulfate, 0.1 mg/ml bovine serum
albumin, 1 mM dithiothreitol, 10% glycerol, 0.25 ,uM [a-32P]dATP
(400 Ci/mmol), 0.5 jig 429 DNA-TP complex, 20 ng purified TP,
20 ng purified 429 DNA polymerase and the indicated amounts of either
wild-type or mutant p6 proteins. After incubation for 5 min at 15°C, the
reaction was stopped by adding up to 10 mM EDTA and 0.1% SDS,
and the samples were filtered through Sephadex G-50 spin columns in
the presence of 0. I% SDS. The initiation complex formed was analyzed
by SDS-PAGE as described (Penialva and Salas, 1982). Quantitation
was performed by densitometric scans of the exposed film in a Molecular
Dynamics 300A densitometer.
DNase I footprinting
DNase I footprinting was carried out essentially as described (Galas and
Schmitz, 1978). The 32P-labeled HindIll 429 DNA right terminal
fragment (2 ng) was incubated in the presence of the indicated amounts
of either wild-type or mutant p6 proteins in a final volume of 25 p1 of
the initiation reaction mixture. In the interference experiment the buffer
contained 36 instead of 20 mM ammonium sulfate. For peptide or
distamycin footprinting the DNA fragment was incubated, with the
indicated amounts of peptide and/or distamycin, in a 20 ,l buffer
containing 50 mM Tris-HCI, pH 7.5 and 10 mM MgCl2. When the
DNA fragment containing direct repeats of the protein p6 high-affinity
binding unit (Serrano et al., 1993) was used, 2 ng of the fragment were
incubated with 6 .g of wild-type protein p6 or 1 jig of wild-type peptide
in 20 p1 of a solution containing 50 mM Tris-HCl, pH 7.5, and 10 mM
MgCl2. To improve binding, the incubation and DNase I digestion were
carried out at 15°C in all cases, except in the distamycin experiment
which was performed at 0°C.
Glutaraldehyde crosslinking of protein p6
Glutaraldehyde crosslinking was carried out essentially as described
(Balzer et al., 1992). Either wild-type or mutant p6 proteins, 3 jig each,
were incubated at room temperature in 40 jl of triethanolamine, pH 8.0,
50 mM NaCl and 500 jiM glutaraldehyde. After 1 h incubation, the
reaction was stopped by adding Tris-HCI, pH 7.5 up to 150 mM.
Samples were analyzed by SDS gel electrophoresis in a 10-20%
polyacrylamide gradient.
Circular dichroism
CD spectra were recorded using a Jasco-600 dichrograph. Samples were
prepared at room temperature in 10 mM sodium phosphate, pH 7.5,
containing 50 mM NaCl. 429 DNA and wild-type peptide were used at
concentrations of 50 jig/mI. When both peptide and DNA were incubated
together, samples were centrifuged at 5000 g for 10 min to remove
insoluble material. The DNA and peptide concentrations were calculated,
before CD analysis, by absorbance at 260 nm and by amino acid analysis,
respectively. Spectra were recorded from 310 to 200 nm using a 1 cm
path length cuvette. Molar ellipticity was calculated per amino acid
residue assuming a mean Mr of 114.6.
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